cyclosporine has been researched along with Adamantiades-Behcet Disease in 136 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 55 (40.44) | 18.2507 |
2000's | 47 (34.56) | 29.6817 |
2010's | 31 (22.79) | 24.3611 |
2020's | 3 (2.21) | 2.80 |
Authors | Studies |
---|---|
Hasumi, Y; Ida, Y; Ishihara, M; Kawano, S; Kimura, I; Mizuki, N; Shibuya, E; Takeuchi, M; Yamane, T | 1 |
Cetinkaya, F; Hamuryudan, V; Hatemi, G; Melikoglu, M; Ozguler, Y; Seyahi, E; Tascilar, K; Ugurlu, S; Yazici, H | 1 |
Eid, RE; Merashli, M; Uthman, I | 1 |
Cai, JF; Chen, Y; Guan, JL; Hua, YQ; Ma, HF; Shen, Y; Zou, J | 1 |
Agarwal, A; Gupta, G; Gupta, PC; Jinagal, J; Negi, A; Ram, J; Sharma, V | 1 |
Bhattarai, D; Gupta, A; Suri, D; Vignesh, P | 1 |
Jain, S; Naidu, S; Sharma, A; Singh, P | 1 |
Chen, TL; Wang, LS | 1 |
Corduneanu, A; Gherasim, V; Sevciuc, R | 1 |
Ishida, Y; Itokawa, T; Koyama, Y; Toyonaga, Y; Yamazaki, K | 1 |
Altun, B; Cinar, M; Dinc, A; Erdem, H; Gezer, M; Karadag, O; Karaman, M; Pay, S; Yazisiz, V; Yilmaz, S | 1 |
Atalay, E; Özkök, A; Özyazgan, Y; Uçar, D; Yıldırım, Y | 1 |
Hirohata, S | 2 |
Hirohata, S; Ishigatsubo, Y; Kikuchi, H; Kuwana, M; Nagafuchi, H; Sawada, T; Takeno, M | 1 |
Brocklehurst, P; Glenny, AM; Gorodkin, R; Pemberton, MN; Riley, P; Taylor, J; Walsh, T | 1 |
Bunce, C; Calder, VL; Haskard, DO; Lightman, S; Longhurst, H; Lynn, W; Moots, R; Stanford, M; Taylor, SR; Tomkins-Netzer, O; Yang, D | 1 |
Furukawa, S; Hayashi, K; Hirose, T; Kohguchi, K; Matsuhashi, Y; Sugihara, T; Tasaka, T; Tohyama, K; Wada, H | 1 |
Chung, YR; Lee, ES; Lee, K; Park, JY; Song, JH | 1 |
Abe, S; Ebe, H; Hagiwara, S; Hoshi, S; Kondo, Y; Kurata, I; Matsumoto, I; Ogishima, H; Oshika, T; Sumida, T; Suzuki, T; Takahashi, H; Tsuboi, H; Umeda, N | 1 |
Aktas, Z; Cubuk, MO; Gurelik, G; Hasanreisoglu, B; Hasanreisoglu, M; Ozdek, S | 1 |
Chen, WL; Lin, CJ; Lin, HJ; Lin, JM; Tien, PT; Tsai, YY | 1 |
Chighizola, CB; Meroni, PL; Ong, VH | 1 |
Al-Hemidan, AI; Tabbara, KF | 1 |
Kim, DW; Lee, BI; Park, SH | 1 |
Kamoi, K; Kawaguchi, T; Mochizuki, M; Sugita, S; Tanaka, H; Yamada, Y | 1 |
Akman, A; Alpsoy, E | 1 |
Kasugai, C; Masuda, Y; Matsumoto, Y; Mizutani, K; Mukai, T; Tamada, Y; Watanabe, D; Zako, M | 1 |
Bouomrani, S; Braham, R; Hammami, S; Mahjoub, S | 1 |
Chen, L; Chi, W; Huang, X; Liu, X; Wang, Y; Yang, P; Zhu, X | 1 |
Gil, H; Hafsaoui, C; Magy-Bertrand, N; Martin, M; Meaux-Ruault, N | 1 |
Horie, S; Kaneko, S; Mochizuki, M; Sugita, S; Yamada, Y | 1 |
Al-Obeidan, SS; El-Asrar, AM; Geboes, K; Kangave, D; Opdenakker, G; Struyf, S; Van Damme, J | 1 |
Hagihara, K; Hirano, T; Hohki, S; Kishimoto, T; Kumanogoh, A; Narazaki, M; Ogata, A; Ohguro, N; Shima, Y; Tanaka, T; Yoshizaki, K | 1 |
Floccari, F; Granata, A | 1 |
Fujiki, Y; Hanafusa, T; Hata, K; Makino, S; Ozaki, T; Takeuchi, T; Yoshida, S; Yoshikawa, A | 1 |
Deuter, C; Ernemann, U; Fierlbeck, G; Horger, M; Kötter, I; Melms, A; Schanz, S; Xenitidis, T | 1 |
Fujino, Y; Kaburaki, T; Kawashima, H; Okinaga, K; Takamoto, M; Yoshida, A | 1 |
Caravatti, M; Germann, D; Schulthess, G; Uebelhart, D; Welzl-Hinterkörner, E; Wiesli, P | 1 |
Kaklamani, VG; Kaklamanis, PG; Markomichelakis, N | 1 |
Kikuchi, S; Niino, M; Shinpo, K; Tashiro, K; Terae, S | 1 |
Hashimoto, T | 2 |
Firat, E; Ortaç, S; Ozdal, PC; Taskintuna, I | 1 |
Baglivo, E; Chaloupka, K; Chizzolini, C; Delavelle, J; Hofer, M; Rossillion, B; Safran, AB | 1 |
Cho, KH; Hwang, CY; Kim, HM; Kim, MS; Kim, SO; Lee, JM; Lim, WK | 1 |
Dogan, D; Farah, C | 1 |
Arimura, Y; Fujii, Y; Marumo, T; Nakabayashi, K; Takahashi, N; Toki, T; Yamada, A; Yoshihara, K | 1 |
Kaneko, F; Nakamura, K; Sato, M; Tojo, M; Zhang, JZ; Zheng, X | 1 |
Chams, H; Chams-Davatchi, C; Davatchi, F; Jamshidi, AR; Nadji, A; Shahram, F; Shizarpour, M | 1 |
Ermakova, NA | 1 |
Asano, S; Iseki, T; Nagamura, F; Ooi, J; Takahashi, S; Takahashi, T; Tojo, A; Tomonari, A; Uchimaru, K | 1 |
Atul, S; Mohan, H; Sarbmeet, L; Singh, R; Vikas, A | 1 |
Herbort, CP; Hiroz, CA; Klaeger, AJ; Morisod, L; Tran, VT | 1 |
Moisés, J; Oppenheimer, F; Torregrosa, JV; Ybarra, J | 1 |
Sheu, SJ; Yang, CA | 1 |
Bulbul, EB; Cikman, ST; Dilek, K; Saricaoglu, H; Tunali, S | 1 |
Krause, L | 1 |
Pleyer, U | 1 |
Kihara, M; Kusunoki, S; Mitsui, M; Mitsui, Y; Takahashi, M; Urakami, R | 1 |
Abe, T; Aoki, M; Itoyama, Y; Kaku, M; Nagai, M; Nakamura, M; Shiga, Y; Yano, A | 1 |
Iliopoulos, A; Katsaros, E; Kedikoglou, S; Kourouklis, S; Laxanis, S | 1 |
Kitaichi, N; Ohno, S | 1 |
Nojima, Y | 1 |
Ahn, JK; Chung, H; Oh, FS; Seo, JM; Yu, HG; Yu, J | 1 |
Gül, A; Inanc, M; Kamali, S; Kasapoglu, E; Mudun, A; Tugal-Tutkun, I; Urgancioglu, M | 1 |
Batra, M; Fierlbeck, G; Günaydin, I; Kötter, I; Melms, A; Stübiger, N; Vonthein, R | 1 |
Ahn, JK; Chung, H; Park, SW; Park, YG; Yoon, KC; Yu, HG | 1 |
Boura, P; Kamali, S; Sarantopoulos, A; Skendros, P; Topouzis, F; Tselios, K | 1 |
Bang, D; Bodaghi, B; Chamberlain, AM; Gul, A; Hatemi, G; Houman, MH; Kötter, I; Olivieri, I; Salvarani, C; Sfikakis, PP; Silman, A; Siva, A; Stanford, MR; Stübiger, N; Yazici, H; Yurdakul, S | 1 |
Baumgärtel, MW; Berlit, P; Krämer, M; Neuen-Jacob, E | 1 |
Martínez-Yélamos, A; Martínez-Yélamos, S; Pujol, R; Riera-Mestre, A; Vidaller, A | 1 |
Benchekroun, N; Berraho-Hamani, A; Chaoui, Z; el Aouni, A; Hajji, Z; Ouazzani, B | 1 |
Ahmadieh, H; Amiransari, B; Azarmina, M; Ehyaee, V; Hassanein, K; Parvin, M; Sajjadi, H; Soheilian, M | 1 |
Nasonov, EL; Nasonova, VA; Shtutman, VZ | 1 |
Hayasaka, S; Kawamoto, K; Kodama, T; Noda, S | 1 |
Nussenblatt, RB; Salvo, EC; Whitcup, SM | 1 |
Atmaca, LS; Batioğlu, F | 1 |
Bambara, LM; Biasi, D; Botto, M; Caramaschi, P; Cortina, P; Girelli, D; Lombardo, G; Lunardi, C; Pacor, ML; Urbani, G | 1 |
al-Ayoubi, M; Ruzicka, T; Süss, R | 1 |
Ariizumi, M; Inui, A; Saga, T; Sato, H; Shogi, E; Suemitsu, T | 1 |
Barak, V; BenEzra, D; Kalichman, I; Maftzir, G | 1 |
Bolliger, CT; Dalquen, P; Elsasser, S; Gonon, M; Grädel, E; Imhof, E; Perruchoud, AP; Solèr, M; Steinbrich, W | 1 |
Aoi, K; Ishibe, Y; Mukuzono, H; Taooka, Y; Yamana, S; Yamanishi, Y | 1 |
Dürk, H; Fierlbeck, G; Kötter, I; Pleyer, U; Saal, J; Ziehut, M | 1 |
Dürk, H; Eckstein, A; Fierlbeck, G; Kötter, I; Saal, JG; Zierhut, M | 1 |
Ruzicka, T | 1 |
Miura, K; Sakane, T | 1 |
Baldrati, L; Capponcini, C; Docci, D; Facchini, F; Feletti, C; Giudicissi, A | 1 |
Avci, O; Güneş, AT; Gürler, N | 1 |
Barak, V; Benezra, D; Maftzir, G | 1 |
Mochizuki, M | 1 |
Nussenblatt, RB | 1 |
Bambauer, R; Klinkmann, J; Latza, R; Schiel, R | 1 |
Bekiroğlu, N; Ergun, T; Gürbüz, O; Hamuryudan, V; Yazici, H; Yurdakul, S | 1 |
Scott, DG; Somerville, MF | 1 |
Săceleanu, AM; Stan, C | 1 |
Chatterjee, A; D'Souza, RJ | 1 |
Morse, LS; Reed, JB; Schwab, IR | 1 |
Bocker, T; Görnig, M; Kaatz, M; Wollina, U; Zouboulis, CC | 1 |
Aritürk, N; Erkan, D; Mohajeri, F; Oge, I; Süllü, Y | 1 |
Sakane, T | 1 |
Minami, M; Nakamura, S; Nakazawa, M; Ohno, S; Sugi-Ikai, N | 1 |
Arda, O; Noyan, U; Yilmaz, S | 1 |
McCune, WJ; Singer, NG | 1 |
Demedts, M; Van Haecke, P; Vansteenkiste, J | 1 |
Chmielewska, B; Jotowicz, E; Pawlicka, L; Remiszewski, P; Rowińska-Zakrzewska, E; Wiatr, E | 1 |
Kotake, S; Matsuda, H; Muramatsu, M; Sasamoto, Y; Yamawaki, S; Yoshikawa, K | 1 |
Dimitrijevic, M; Glisic, B; Mitrovic, D; Pavlica, L; Popovic, M | 1 |
Higashi, K; Kotake, S; Matsuda, H; Okamoto, T; Sasamoto, Y; Yoshikawa, K | 1 |
ten Hoopen-Neumann, H; van der Meijden, WI; van Hagen, PM | 1 |
Bangerter, M; Griesshammer, M; Hafner, M; Heil, G; Heiss, M; Kern, P; Kern, W; Krauter, J; v Tirpitz, C | 1 |
de Vries, AL; van Vliet, IM | 1 |
Amano, J; Imamura, H; Isobe, M; Kitabayashi, H; Koizumi, T; Nagano, S; Yasuo, M; Yazaki, Y | 1 |
Ausejo, M; Saenz, A; Shea, B; Tugwell, P; Welch, V; Wells, G | 1 |
Sakane, T; Takeno, M | 2 |
Dayan, M; de Smet, MD | 1 |
Kaklamani, VG; Kaklamanis, PG | 1 |
Aktuğlu, Y; Mert, A; Oztürk, R; Pamuk, GE; Pamuk, ON; Tabak, F | 1 |
Bieber, T; Wenzel, J | 1 |
Beiran, I; Miller, B; Scharf, J; Seider, N | 1 |
Bimstein, E; Irshied, J | 1 |
Fujino, Y; Kaburaki, T; Kato, S; Kato, Y; Kawashima, H; Numaga, J | 1 |
Aktunç, T; Hamuryudan, V; Işçimen, A; Müftüoğlu, A; Ozyazgan, Y; Pazarli, H; Tüzün, B; Tüzün, Y; Yazici, H; Yurdakul, S | 1 |
Artola Urain, T; Campo Hernández, JM; Márquez de Prado Urquía, MM; Sanz Franco, M | 1 |
Antonios, SR; Chavis, PS; Tabbara, KF | 1 |
Ichiishi, A; Kosaka, S; Kotake, S; Matsuda, H; Minagawa, R; Yoshikawa, K | 1 |
Peter, RU; Ruzicka, T | 1 |
Duerk, H; Grossmann, T; Knorr, M; Lingenfelser, T; Saal, JG; Stevens, A | 1 |
Fathman, CG; Myers, BD | 1 |
Barnes, CG; Yazici, H | 1 |
Amrom, D; Buisseret, T | 1 |
Kikuchi, M; Kobayashi, I; Maruyama, S; Shibata, K; Takeuchi, M | 1 |
Kashiwagi, H | 1 |
Hasegawa, Y; Okada, H; Okamoto, S | 1 |
31 review(s) available for cyclosporine and Adamantiades-Behcet Disease
Article | Year |
---|---|
A review of current management of vasculo-Behcet's.
Topics: Adalimumab; Aneurysm; Anticoagulants; Antirheumatic Agents; Azathioprine; Behcet Syndrome; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Interleukin 1 Receptor Antagonist Protein; Rituximab; Thrombosis; Vascular Surgical Procedures | 2018 |
[Recent aspects of Neuro-Behcet's disease].
Topics: Antibodies, Monoclonal; Behcet Syndrome; Chronic Disease; Cyclosporine; Disease Progression; Humans; Infliximab; Interleukin-6 | 2013 |
Interventions for the management of oral ulcers in Behçet's disease.
Topics: Acyclovir; Adrenal Cortex Hormones; Alanine; Behcet Syndrome; Colchicine; Cyclosporine; Etanercept; Humans; Immunoglobulin G; Interferon-alpha; Oral Ulcer; Quinolones; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Stomatitis, Aphthous; Sucralfate; Thalidomide | 2014 |
Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behçet's Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis.
Topics: Adrenal Cortex Hormones; Adult; Behcet Syndrome; Cyclosporine; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Infliximab; Male; Renal Dialysis; Treatment Outcome; Uveitis; Visual Acuity | 2015 |
The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.
Topics: Adult; Arthritis, Juvenile; Behcet Syndrome; Child; Cyclosporine; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Activation; Rheumatology; Sjogren's Syndrome; Still's Disease, Adult-Onset; T-Lymphocytes; Virus Replication | 2017 |
Behçet's disease: an algorithmic approach to its treatment.
Topics: Adrenal Cortex Hormones; Behcet Syndrome; Blood Vessels; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Humans; Immunosuppression Therapy; Mucous Membrane; Multiple Organ Failure; Practice Guidelines as Topic; Skin | 2009 |
[Central nervous system involvement in Behçet's disease].
Topics: Acute Disease; Behcet Syndrome; Biomarkers; Chronic Disease; Cyclosporine; HLA-B Antigens; HLA-B51 Antigen; Humans; Interleukin-6; Magnetic Resonance Imaging; Methotrexate | 2001 |
Intracranial hemorrhage in neuro-Behçet's syndrome.
Topics: Adult; Behcet Syndrome; Brain; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Intracranial Hemorrhages; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, X-Ray Computed | 2002 |
[Behçet disease].
Topics: Anti-Inflammatory Agents; Behcet Syndrome; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Prednisone; Treatment Outcome | 2002 |
[Adamantiades-Behcet's disease].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Behcet Syndrome; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Etanercept; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Panuveitis; Receptors, Tumor Necrosis Factor; Retinal Vasculitis; Tumor Necrosis Factor-alpha | 2005 |
[Behçet's disease].
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antigens, Bacterial; Autoantibodies; Behcet Syndrome; Colchicine; Cyclosporine; Glucocorticoids; Heat-Shock Proteins; HLA-B Antigens; HLA-B51 Antigen; Humans; Immunosuppressive Agents; Infliximab; Molecular Mimicry; Streptococcus sanguis; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2005 |
[Cyclosporin].
Topics: Anemia, Aplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autoimmune Diseases; Behcet Syndrome; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Food-Drug Interactions; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation | 2005 |
[Prospects of the use of cyclosporin A in rheumatic diseases].
Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Behcet Syndrome; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Cyclosporine; Dermatomyositis; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Rheumatic Diseases; Sjogren's Syndrome | 1994 |
[A case of cyclosporin A-induced myopathy].
Topics: Adult; Behcet Syndrome; Colchicine; Creatine Kinase; Cyclosporine; Humans; Male; Muscular Diseases; Visual Acuity | 1993 |
Therapy of Behçet's disease.
Topics: Azathioprine; Behcet Syndrome; Colchicine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Interferons; Retrospective Studies; Steroids; Treatment Outcome | 1996 |
[Behçet's disease].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Azathioprine; Behcet Syndrome; Clinical Trials as Topic; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Plasmapheresis; Prednisolone; Prognosis | 1996 |
Cyclosporin in less common immune-mediated skin diseases.
Topics: Behcet Syndrome; Cyclosporine; Dermatologic Agents; Humans; Immune System Diseases; Skin Diseases | 1996 |
[Research for basic and clinical aspects of Behcet's disease--recent advance and future--].
Topics: Animals; Behcet Syndrome; Cyclosporine; Female; Heat-Shock Proteins; HLA-B Antigens; Humans; Immunosuppressive Agents; Male; Neutrophils; Reference Standards; T-Lymphocytes; Tacrolimus | 1996 |
Immunotherapy for Behçet's disease.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Agents; Behcet Syndrome; Colchicine; Cyclosporine; Humans; Immunosuppressive Agents; Immunotherapy; Ligands; Tacrolimus; Uveitis | 1997 |
Uveitis in Behçet's disease.
Topics: Adrenal Cortex Hormones; Anterior Eye Segment; Behcet Syndrome; Cataract; Colchicine; Cyclosporine; Humans; Tacrolimus; Uveitis; Vitreous Body | 1997 |
[Behçet's disease with a fatal evolution].
Topics: Acute Disease; Adult; Behcet Syndrome; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fatal Outcome; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Optic Neuritis; Prednisone | 1997 |
[Physiopathology and therapy of Behcet's syndrome].
Topics: Behcet Syndrome; Chaperonin 60; Cyclosporine; Cytokines; Drug Administration Schedule; Female; HLA-B Antigens; HLA-B51 Antigen; Humans; Immunosuppressive Agents; Male; Tacrolimus | 1998 |
Update on immunosuppressive therapy.
Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver; Lung; Lung Injury; Lupus Erythematosus, Systemic; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retina; Tacrolimus; Thalidomide | 1998 |
[Behçet's disease].
Topics: Behcet Syndrome; Cyclosporine; Immunosuppressive Agents; Methotrexate; Neutrophil Activation; Reference Standards | 1999 |
Pharmacotherapy for Behcet's syndrome.
Topics: Acyclovir; Anti-Infective Agents; Apazone; Azathioprine; Behcet Syndrome; Colchicine; Cyclosporine; Humans; Immunosuppressive Agents; Interferon-alpha; Penicillins | 2000 |
Current therapy in Behcet's disease.
Topics: Adrenal Cortex Hormones; Behcet Syndrome; Colchicine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Prognosis; Treatment Outcome | 2000 |
Novel approaches to Behçet's disease.
Topics: Antiviral Agents; Behcet Syndrome; Cyclosporine; Humans; Immunosuppressive Agents; Interferon-alpha; Thalidomide | 2000 |
[Cyclosporin A in the therapy of inflammatory dermatoses].
Topics: Behcet Syndrome; Cyclosporine; Dermatitis; Dermatitis, Atopic; Humans; Lichen Planus; Photosensitivity Disorders; Psoriasis; Pyoderma Gangrenosum; Scleroderma, Localized | 1992 |
Practical treatment recommendations for pharmacotherapy of Behçet's syndrome.
Topics: Administration, Oral; Adrenal Cortex Hormones; Behcet Syndrome; Colchicine; Cyclosporine; Humans; Immunosuppressive Agents; Injections, Intravenous | 1991 |
[A case of Behçet's disease associated with myopathy during cyclosporin treatment].
Topics: Behcet Syndrome; Cyclosporine; Humans; Male; Middle Aged; Muscular Diseases | 1991 |
[Neuro-Behçet disease with bilateral cheiro-oral syndrome following simultaneous multiple brain hemorrhage].
Topics: Adult; Behcet Syndrome; Cerebral Hemorrhage; Cyclosporine; Humans; Magnetic Resonance Imaging; Male; Nervous System Diseases; Pons; Sensation; Syndrome | 1991 |
12 trial(s) available for cyclosporine and Adamantiades-Behcet Disease
Article | Year |
---|---|
An open-label, prospective, single-arm study of switching from infliximab to cyclosporine for refractory uveitis in patients with Behçet's disease in long-term remission.
Topics: Behcet Syndrome; Cyclosporine; Humans; Infliximab; Prospective Studies; Treatment Outcome; Uveitis | 2021 |
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lymphocyte Count; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Single-Blind Method; Surveys and Questionnaires; T-Lymphocytes, Regulatory; Tacrolimus; Th17 Cells; Treatment Outcome | 2015 |
Could nicotine be beneficial for Behçet's disease?
Topics: Adult; Azathioprine; Behcet Syndrome; Colchicine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Nicotine; Prednisolone; Prospective Studies; Smoking; Treatment Outcome | 2002 |
Efficacy of corticosteroids and cyclosporin in the treatment of retinal vasculitis in patients with Behçet's disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Behcet Syndrome; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Retinal Diseases; Retinal Vasculitis; Treatment Outcome; Visual Acuity | 2003 |
[Intraocular inflammations. A diagnostic and therapeutic challenge].
Topics: Antiviral Agents; Behcet Syndrome; Chronic Disease; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Prognosis; Recombinant Proteins; Uveitis; Vision, Low | 2005 |
Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Resistance, Multiple; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Retreatment; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis | 2005 |
Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy.
Topics: Adult; Behcet Syndrome; Cyclosporine; Female; Humans; Male; Time Factors; Treatment Outcome; Uveitis; Visual Acuity | 1994 |
Cyclosporine and therapeutic plasma exchange in treatment of progressive autoimmune diseases.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibody Formation; Azathioprine; Behcet Syndrome; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Nephrotic Syndrome; Plasma Exchange; Prospective Studies; Proteinuria; Quality of Life | 1997 |
Topical cyclosporine-A for treatment of oral ulcers of Behçet's syndrome.
Topics: Administration, Topical; Adult; Behcet Syndrome; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Oral Ulcer; Treatment Outcome | 1997 |
Neoral--new cyclosporin for old?
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Behcet Syndrome; Biological Availability; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy; Emulsions; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Rheumatic Diseases; Severity of Illness Index; Surveys and Questionnaires | 1997 |
Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial.
Topics: Adolescent; Adult; Behcet Syndrome; Cyclophosphamide; Cyclosporine; Female; Humans; Male; Single-Blind Method; Time Factors; Visual Acuity | 1992 |
Cyclosporine effects on optic nerve and retinal vasculitis in Behçet's disease.
Topics: Adult; Behcet Syndrome; Cyclosporine; Humans; Longitudinal Studies; Male; Optic Atrophy; Prednisone; Prospective Studies; Retinal Vessels; Vasculitis | 1992 |
93 other study(ies) available for cyclosporine and Adamantiades-Behcet Disease
Article | Year |
---|---|
Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome.
Topics: Adult; Azathioprine; Behcet Syndrome; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Femoral Vein; Glucocorticoids; Humans; Iliac Vein; Immunosuppressive Agents; Interferon-alpha; Lower Extremity; Male; Methylprednisolone; Popliteal Vein; Prednisolone; Proportional Hazards Models; Recurrence; Treatment Outcome; Ultrasonography, Doppler; Vena Cava, Inferior; Venous Thrombosis; Young Adult | 2020 |
Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.
Topics: Antirheumatic Agents; Behcet Syndrome; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Pneumonia; Thalidomide | 2017 |
Immune keratitis: An unusual primary presentation of neuro-Behçet's disease.
Topics: Behcet Syndrome; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Keratitis; Lubricant Eye Drops; Male; Methylprednisolone; Slit Lamp Microscopy; Visual Acuity; Young Adult | 2019 |
Pathergy phenomenon: an important clinical pointer to Behҫet disease.
Topics: Anti-Inflammatory Agents; Behcet Syndrome; Child, Preschool; Cicatrix; Cyclosporine; Dermatologic Agents; Female; Humans; Prednisolone; Skin Diseases; Skin Tests | 2019 |
Cyclosporine-induced pericarditis: an elusive cause of chest pain in Behçet's disease.
Topics: Adolescent; Behcet Syndrome; Chest Pain; Cyclosporine; Diagnosis, Differential; Drug Substitution; Humans; Immunosuppressive Agents; Male; Pericarditis | 2019 |
Leptospiral presentation in Behçet's disease: A case report.
Topics: Administration, Intravenous; Adult; Behcet Syndrome; Cyclosporine; Female; Humans; Leptospira; Leptospirosis; Male; Oral Ulcer; Penicillins; Polymerase Chain Reaction; Prednisone; Treatment Outcome | 2020 |
[Behcet disease -- case report].
Topics: Adult; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Erythema Nodosum; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Intravitreal Injections; Macular Edema; Retinal Detachment; Stomatitis, Aphthous; Treatment Outcome; Triamcinolone | 2012 |
Primary effusion lymphoma-like lymphoma unrelated to human herpesvirus 8 with aggressive clinical course in patient receiving cyclosporine.
Topics: Aged; Behcet Syndrome; Cyclosporine; Epstein-Barr Virus Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma; Lymphoma, Primary Effusion; Male; Neoplasm Recurrence, Local | 2013 |
Systemic involvements and preferred treatments in a large cohort of Behçet's disease.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Behcet Syndrome; Cohort Studies; Colchicine; Comorbidity; Cyclosporine; Female; Hospitals, Military; Humans; Immunosuppressive Agents; Male; Retrospective Studies; Treatment Outcome; Turkey | 2013 |
An exceptional case of full-thickness macular hole closure in a patient with Behçet disease.
Topics: Administration, Oral; Administration, Topical; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Male; Panuveitis; Recombinant Proteins; Remission, Spontaneous; Retinal Perforations; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2014 |
Analysis of various factors on the relapse of acute neurological attacks in Behçet's disease.
Topics: Acute Disease; Adult; Behcet Syndrome; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Surveys and Questionnaires | 2014 |
Delayed false elevation of circulating tacrolimus concentrations after cord blood transplantation in a patient with myelodysplastic syndrome.
Topics: Behcet Syndrome; Cord Blood Stem Cell Transplantation; Cyclosporine; False Positive Reactions; Graft vs Host Disease; Humans; Immunoassay; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Tacrolimus | 2014 |
Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
Topics: Adult; Behcet Syndrome; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Recurrence; Remission Induction; Treatment Outcome; Turkey; Uveitis; Visual Acuity | 2015 |
Interferon Alpha-2a Therapy in Patients with Refractory Behçet Uveitis.
Topics: Adolescent; Adult; Azathioprine; Behcet Syndrome; Child; Cyclosporine; Drug Combinations; Drug Resistance; Female; Fluorescein Angiography; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Tomography, Optical Coherence; Uveitis; Visual Acuity | 2017 |
Occlusive retinal vasculitis secondary to Behçet's disease.
Topics: Adult; Anti-Inflammatory Agents; Behcet Syndrome; Cyclosporine; Dexamethasone; Fever; Fluorescein Angiography; Humans; Intravitreal Injections; Male; Prednisolone; Retinal Vasculitis; Treatment Outcome; Vision Disorders | 2017 |
Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Behcet Syndrome; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Methotrexate; Prednisone; Recurrence; Retinal Vasculitis; Retrospective Studies; Treatment Outcome; Visual Acuity; Young Adult | 2008 |
Accelerated healing of pyoderma gangrenosum in Behçet patient treated with cyclosporine and split thickness skin graft.
Topics: Antifungal Agents; Behcet Syndrome; Combined Modality Therapy; Cyclosporine; Debridement; Female; Humans; Middle Aged; Pyoderma Gangrenosum; Skin Transplantation; Transplantation, Autologous; Wound Healing | 2008 |
Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Behcet Syndrome; Cyclosporine; Drug Evaluation; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Retrospective Studies; Secondary Prevention; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Visual Acuity | 2010 |
Infliximab treatment of severe genital ulcers associated with Behçet disease.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Behcet Syndrome; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infliximab; Retreatment; Tumor Necrosis Factor-alpha; Ulcer | 2010 |
[Ciclosporin-associated cerebral tumor-like location of Behçet's disease].
Topics: Anti-Inflammatory Agents; Behcet Syndrome; Brain Neoplasms; Colchicine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Meningitis; Middle Aged; Prednisone; Tomography, X-Ray Computed | 2010 |
Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A.
Topics: Adult; Behcet Syndrome; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunosuppressive Agents; In Vitro Techniques; Interferon-gamma; Interleukin-17; Lymphocyte Activation; Male; Monocytes; Staining and Labeling; T-Lymphocytes; Time Factors | 2010 |
[Role of cyclosporine in the occurrence of neuro-Behçet's disease?].
Topics: Algeria; Behcet Syndrome; Cyclosporine; Humans; Incidence; Male; Middle Aged | 2010 |
Induction of regulatory T cells by infliximab in Behcet's disease.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Behcet Syndrome; Colchicine; Cyclosporine; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Forkhead Transcription Factors; Humans; Infliximab; T-Lymphocytes, Regulatory; Toxoplasmosis, Ocular; Tumor Necrosis Factor-alpha; Uveitis; Uveomeningoencephalitic Syndrome | 2011 |
Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aqueous Humor; Behcet Syndrome; Cyclosporine; Cytokines; Female; HLA-B27 Antigen; Humans; Interferon-gamma; Interleukin-10; Interleukin-15; Interleukin-17; Logistic Models; Male; Middle Aged; Th1 Cells; Th17 Cells; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Uveomeningoencephalitic Syndrome; Young Adult | 2011 |
A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Behcet Syndrome; Colchicine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunologic Factors; Infliximab; Middle Aged; Prednisolone; Receptors, Interleukin-6; Remission Induction; Treatment Failure | 2012 |
Behcet's disease and focal segmental glomerulosclerosis: an unusual association.
Topics: Angiotensin-Converting Enzyme Inhibitors; Behcet Syndrome; Cyclosporine; Diuretics; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Male; Nephrotic Syndrome; Treatment Outcome; Young Adult | 2012 |
Good response to infliximab in a patient with deep vein thrombosis associated with Behçet disease.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Recurrence; Treatment Outcome; Venous Thrombosis | 2012 |
[Behçet's disease].
Topics: Behcet Syndrome; Cyclosporine; Humans; Immunosuppressive Agents; Steroids | 2012 |
Clinical background comparison of patients with and without ocular inflammatory attacks after initiation of infliximab therapy.
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Behcet Syndrome; Colchicine; Cyclosporine; Female; Glucocorticoids; Humans; Infliximab; Infusions, Intravenous; Male; Middle Aged; Retinitis; Retrospective Studies; Uveitis; Visual Acuity; Young Adult | 2012 |
Coincidence of Behçet's disease and SAPHO syndrome.
Topics: Acquired Hyperostosis Syndrome; Administration, Oral; Adolescent; Behcet Syndrome; Clavicle; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Prednisone; Radiography, Thoracic; Radionuclide Imaging; Technetium Tc 99m Medronate; Treatment Outcome | 2002 |
[Progress in the study of allergy and collagen disease in the last 100 years: Behcet disease].
Topics: Behcet Syndrome; Cyclosporine; History, 20th Century; HLA-B Antigens; Humans; Immunosuppressive Agents | 2002 |
Long-term therapy with low dose cyclosporin A in ocular Behçet's disease.
Topics: Adult; Behcet Syndrome; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Uveitis, Posterior | 2002 |
[Cerebral sinus thrombosis in Behçet disease: case report and review of the literature].
Topics: Adolescent; Anticoagulants; Behcet Syndrome; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Fluorescein Angiography; Follow-Up Studies; Humans; Immunosuppressive Agents; Magnetic Resonance Angiography; Male; Prednisone; Sinus Thrombosis, Intracranial | 2003 |
Novel effects of On-Chung-Eum, the traditional plant medicine, on cytokine production in human mononuclear cells from Behçet's.
Topics: Adult; Analysis of Variance; Behcet Syndrome; Case-Control Studies; Cyclosporine; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunocompromised Host; Interferon-gamma; Interleukin-1; Leukocytes, Mononuclear; Male; Middle Aged; Neurotoxicity Syndromes; Phytohemagglutinins; Phytotherapy; Tumor Necrosis Factor-alpha | 2003 |
[A case of Behçet's disease associated with neuromyopathy induced by combination therapy with colchicine and cyclosporin].
Topics: Behcet Syndrome; Colchicine; Cyclosporine; Drug Therapy, Combination; Humans; Male; Middle Aged; Neuromuscular Diseases | 2003 |
Epidemiology of Behçet's disease in Asian countries and Japan.
Topics: Age Distribution; Asia; Behcet Syndrome; China; Cyclosporine; Female; Humans; Immunosuppressive Agents; Japan; Male; Mediterranean Region; Prevalence | 2003 |
Extensive pyoderma gangrenosum-like lesion in two cases of Behçet's disease, responding only to cyclosporin.
Topics: Adult; Behcet Syndrome; Cyclosporine; Humans; Immunosuppressive Agents; Male; Pyoderma Gangrenosum | 2003 |
Resolution of Behçet's disease after HLA-mismatched unrelated cord blood transplantation for myelodysplastic syndrome.
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Autoimmune Diseases; Behcet Syndrome; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Transplantation Conditioning | 2004 |
Behçet's disease with relapsing cutaneous polyarteritis-nodosa-like lesions, responsive to oral cyclosporine therapy.
Topics: Adolescent; Anticoagulants; Azathioprine; Behcet Syndrome; Colchicine; Cyclosporine; Heparin; Humans; Immunosuppressive Agents; Male; Methotrexate; Polyarteritis Nodosa; Prednisone; Thrombophlebitis; Warfarin | 2003 |
Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis.
Topics: Adolescent; Adult; Azathioprine; Behcet Syndrome; Child; Colchicine; Coloring Agents; Cyclosporine; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; HLA-B Antigens; HLA-B51 Antigen; Humans; Immunosuppressive Agents; Indocyanine Green; Male; Ultrasonography; Uveitis, Anterior | 2004 |
Renal transplantation in a C-ANCA(+) patient with Behcet disease and rapidly progressive glomerulonephritis.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Behcet Syndrome; Cyclosporine; Follow-Up Studies; Glomerulonephritis; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Prednisolone; Time Factors | 2004 |
Macular hole in Behcet's disease.
Topics: Adrenal Cortex Hormones; Adult; Behcet Syndrome; Cyclosporine; Eye; Humans; Infant; Male; Pain; Papilledema; Retinal Hemorrhage; Retinal Perforations; Treatment Outcome; Vision Disorders | 2004 |
Effects of long-term cyclosporine A therapy on renal functions in Behçet's disease.
Topics: Adolescent; Adult; Behcet Syndrome; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Kidney; Male; Middle Aged | 2004 |
Behçet disease presenting with neurological complications immediately after conversion from conventional cyclosporin A to microemulsion formulation.
Topics: Administration, Oral; Behcet Syndrome; Brain Diseases; Brain Stem; Cyclosporine; Diagnosis, Differential; Emulsions; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Prednisolone; Remission Induction | 2005 |
[Toxoplasma encephalitis in a patient receiving cyclosporine monotherapy for Behçet disease].
Topics: Adult; Behcet Syndrome; Cyclosporine; Encephalitis; Female; Humans; Opportunistic Infections; Toxoplasmosis, Cerebral | 2005 |
A case of tuberculous meningoencephalitis in a patient with Behçet's disease.
Topics: Adult; Antitubercular Agents; Behcet Syndrome; Colchicine; Cyclosporine; DNA, Bacterial; Drug Therapy, Combination; Humans; Immunocompromised Host; Male; Meningoencephalitis; Mycobacterium tuberculosis; Opportunistic Infections; Prednisolone; Treatment Outcome; Tuberculosis, Meningeal | 2006 |
Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
Topics: Adult; Behcet Syndrome; CD56 Antigen; Cyclosporine; Down-Regulation; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunophenotyping; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Interleukin-4; Male; Middle Aged; Prednisone; Prospective Studies; T-Lymphocyte Subsets; T-Lymphocytes | 2005 |
CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.
Topics: Adolescent; Adult; Autonomic Nervous System Diseases; Azathioprine; Behcet Syndrome; Cohort Studies; Comorbidity; Cyclosporine; Disease Progression; Eye Diseases; Female; Germany; Humans; Immunosuppressive Agents; Incidence; Interferon-alpha; Male; Middle Aged; Prevalence; Retrospective Studies; Severity of Illness Index | 2006 |
Combined low dose cyclosporine and prednisone down-regulate natural killer cell-like effector functions of CD8brightCD56+ T cells in patients with active Behçet uveitis.
Topics: Adult; Behcet Syndrome; CD56 Antigen; CD8-Positive T-Lymphocytes; Cyclosporine; Cytotoxicity Tests, Immunologic; Down-Regulation; Drug Therapy, Combination; Female; Flow Cytometry; Humans; Immunosuppressive Agents; Killer Cells, Natural; Male; Membrane Glycoproteins; Middle Aged; Perforin; Phenotype; Pore Forming Cytotoxic Proteins; Prednisone; Prospective Studies; Receptors, CCR5; Receptors, Interleukin-8A | 2006 |
Concurrent relapsing central nervous system and ocular involvement in a case of life-threatening Adamantiades-Behçet Disease (ABD).
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Behcet Syndrome; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Recurrence; Retinal Vasculitis; Vitreous Body | 2006 |
EULAR recommendations for the management of Behçet disease.
Topics: Anticoagulants; Arthritis; Behcet Syndrome; Cyclosporine; Evidence-Based Medicine; Gastrointestinal Diseases; Humans; International Cooperation; Nervous System Diseases; Skin Diseases; Uveitis; Vascular Diseases | 2008 |
[Myalgia in Neuro-Behçet's disease. Medication side effects or expression of underlying disease].
Topics: Adult; Azathioprine; Behcet Syndrome; Biopsy; Brain Diseases; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electromyography; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Muscle, Skeletal; Neuromuscular Diseases; Optic Neuritis; Prednisone; Uveitis, Posterior | 2008 |
[Neuro-Behçet and neurotoxicity due to cyclosporine].
Topics: Behcet Syndrome; Cyclosporine; Diagnosis, Differential; Humans; Neurotoxicity Syndromes | 2008 |
[Outcome of Behçet disease in ophthalmologic practice in Morocco].
Topics: Adult; Behcet Syndrome; Chlorambucil; Cyclosporine; Eye Diseases; Female; Humans; Male; Morocco; Prednisone; Prognosis; Retinal Diseases; Time Factors; Uveitis | 1995 |
Low dose cyclosporin-A therapy in Behçet's disease.
Topics: Administration, Oral; Adult; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prednisolone; Visual Acuity | 1994 |
Visual prognosis in patients with Behçet's disease receiving colchicine, systemic corticosteroid or cyclosporin.
Topics: Adult; Behcet Syndrome; Colchicine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prednisolone; Prognosis; Retrospective Studies; Visual Acuity | 1994 |
Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease.
Topics: Adolescent; Adult; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Male; Middle Aged; Prednisone; Uveitis; Visual Acuity | 1994 |
The efficacy of cyclosporin-a in the treatment of Behçet's disease.
Topics: Administration, Oral; Adult; Behcet Syndrome; Cyclosporine; Drug Evaluation; Humans; Immunosuppressive Agents; Male; Recurrence; Retinal Vessels; Treatment Outcome; Vasculitis; Visual Acuity | 1994 |
Cyclosporine therapy in Behçet's disease.
Topics: Adult; Behcet Syndrome; Cyclosporine; Female; Genital Diseases, Male; Humans; Male; Middle Aged; Mouth Diseases; Scrotum; Vulvar Diseases | 1993 |
[A ciclosporin A responsive case of Behçet's disease associated with IgA nephropathy].
Topics: Adolescent; Antigen-Antibody Complex; Behcet Syndrome; Cyclosporine; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Male | 1993 |
Serum levels of interleukin-2 receptor in ocular Behçet's disease.
Topics: Behcet Syndrome; Cyclosporine; Drug Combinations; Eye; Eye Diseases; Humans; Methylprednisolone; Pars Planitis; Receptors, Interleukin-2; Reference Values | 1993 |
[Severe hemoptysis in pulmonary vasculitis].
Topics: Adult; Aneurysm; Angiography, Digital Subtraction; Azathioprine; Behcet Syndrome; Cyclosporine; Diagnostic Imaging; Drug Therapy, Combination; Hemoptysis; Humans; Male; Prednisone; Pulmonary Artery | 1993 |
Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura in a patient with Behçet's disease treated with cyclosporin.
Topics: Adult; Behcet Syndrome; Cyclosporine; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Purpura, Thrombotic Thrombocytopenic | 1997 |
Efficacy of cyclosporine on mucocutaneous manifestations of Behçet's disease.
Topics: Adult; Behcet Syndrome; Cyclosporine; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Immunosuppressive Agents; Male; Mucous Membrane; Oral Ulcer; Skin Diseases; Ulcer | 1997 |
Blood serum interleukin-1 receptor antagonist in pars planitis and ocular Behçet disease.
Topics: Behcet Syndrome; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Male; Receptors, Interleukin-1; Sialoglycoproteins; Uveitis, Intermediate | 1997 |
Haemolytic uraemic syndrome during cyclosporin therapy for Behcet's disease.
Topics: Adult; Behcet Syndrome; Cyclosporine; Female; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents | 1997 |
High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behçet retinitis.
Topics: Acute Disease; Behcet Syndrome; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Prednisone; Retinitis; Visual Acuity; Visual Fields | 1998 |
[Late manifestation of a fatal Behçet's disease with cardiac involvement and lethal outcome].
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Behcet Syndrome; Cardiomyopathy, Dilated; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Fatal Outcome; Humans; Immunosuppressive Agents; Male; Prednisolone; Recurrence; Skin; Ultrasonography | 1998 |
Cyclosporin-A therapy in severe uveitis of Behçet's disease.
Topics: Adult; Behcet Syndrome; Colchicine; Cyclophosphamide; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Treatment Outcome; Uveitis, Posterior; Visual Acuity | 1998 |
Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Behcet Syndrome; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Cyclosporine; Female; Flow Cytometry; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Interleukin-4; Kinetics; Male; Middle Aged; Tacrolimus | 1998 |
The effect of cyclosporin-A on the ultrastructure of gingival tissue in Behçet's disease.
Topics: Adolescent; Adult; Behcet Syndrome; Biopsy; Cyclosporine; Female; Gingiva; Gingival Hyperplasia; Humans; Immunosuppressive Agents; Male; Microscopy, Electron | 1993 |
Long-term treatment with cyclosporin A and coumarin in pulmonary thromboembolic Behçet's disease.
Topics: Adult; Aneurysm; Anticoagulants; Behcet Syndrome; Coumarins; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Hemoptysis; Humans; Immunosuppressive Agents; Pulmonary Artery; Pulmonary Embolism | 1998 |
[Behcet's disease with pulmonary vessel involvement].
Topics: Adult; Aneurysm; Behcet Syndrome; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Lung; Prednisone; Pulmonary Artery; Radiography | 1997 |
The development of malignant rhabdoid tumor in a patient with Behçet's disease treated with ciclosporin.
Topics: Adult; Antirheumatic Agents; Behcet Syndrome; Cyclosporine; Humans; Male; Rhabdoid Tumor; Soft Tissue Neoplasms; Thigh | 1998 |
Cyclosporine in the treatment of autoimmune disorders: a 10-year experience.
Topics: Adult; Aged; Arthritis, Rheumatoid; Autoimmune Diseases; Behcet Syndrome; Central Nervous System Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Retrospective Studies; Vasculitis | 1998 |
Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy.
Topics: Adult; Behcet Syndrome; Brain; Brain Diseases; Cohort Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies | 1999 |
[Behcet's disease].
Topics: Adult; Behcet Syndrome; Colchicine; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Prednisone; Sexually Transmitted Diseases; Stomatitis, Aphthous; Treatment Outcome; Uveitis; Vulvar Diseases | 1999 |
Myelodysplastic syndrome with monosomy 7 after immunosuppressive therapy in Behçet's disease.
Topics: Adult; Antineoplastic Agents, Alkylating; Behcet Syndrome; Bone Marrow Cells; Chlorambucil; Chromosomes, Human, Pair 7; Cyclosporine; Fatal Outcome; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Monosomy; Myelodysplastic Syndromes | 1999 |
[Behcet disease].
Topics: Acne Vulgaris; Adult; Antipsychotic Agents; Behcet Syndrome; Cyclosporine; Diagnosis, Differential; Humans; Male; Meningoencephalitis; Mental Disorders; Neurologic Examination; Neuropsychological Tests; Prednisone; Stomatitis, Aphthous; Vision Disorders | 1999 |
Pulmonary embolism due to right ventricular thrombus in a case of Behcet's disease.
Topics: Adult; Behcet Syndrome; Coronary Thrombosis; Cyclosporine; Diagnosis, Differential; Humans; Male; Paresis; Pulmonary Embolism; Ventricular Dysfunction, Right; Warfarin | 1999 |
Prospective determination of T-cell responses to S-antigen in Behçet's disease patients and controls.
Topics: Adult; Arrestin; Behcet Syndrome; Cell Line; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunologic Tests; Immunosuppressive Agents; Lymphocyte Activation; Male; Middle Aged; Prednisone; Prospective Studies; T-Lymphocytes | 2000 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chlorambucil; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferons; Levamisole; Male; Methotrexate; Pentoxifylline; Recombinant Proteins; Recurrence; Sulfasalazine; Thalidomide | 2001 |
Systemic Nocardia infection in a patient with Behçet's disease.
Topics: Adult; Azathioprine; Behcet Syndrome; Brain; Brain Edema; Cyclosporine; Drug Therapy, Combination; Fatal Outcome; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Male; Nocardia; Nocardia Infections; Tomography, X-Ray Computed | 2001 |
Cyclosporin A in treatment of refractory adult polymyositis/dermatomyositis.
Topics: Adult; Aged; Arthritis, Psoriatic; Behcet Syndrome; Cyclosporine; Dermatomyositis; Female; Follow-Up Studies; Humans; Muscular Diseases; Polymyositis; Risk Assessment | 2001 |
Intravenous immunoglobulin therapy for resistant ocular Behçet's disease.
Topics: Adolescent; Adult; Behcet Syndrome; Cyclosporine; Drug Administration Schedule; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Panuveitis; Treatment Failure; Treatment Outcome | 2001 |
Oral diagnosis of Behcet disease in an eleven-year old girl and the non-surgical treatment of her gingival overgrowth caused by Cyclosporine.
Topics: Behcet Syndrome; Child; Cyclosporine; Dental Plaque; Dental Prophylaxis; Diagnosis, Differential; Female; Follow-Up Studies; Gingival Hemorrhage; Gingival Overgrowth; Gingivitis; Humans; Immunosuppressive Agents; Oral Hygiene; Patient Care Planning; Treatment Outcome; Uveitis | 2001 |
Central nervous system symptoms in a population of Behçet's disease patients with refractory uveitis treated with cyclosporine A.
Topics: Adolescent; Adult; Behcet Syndrome; Brain; Brain Diseases; Cyclosporine; Humans; Immunosuppressive Agents; Male; Middle Aged; Uveitis, Anterior | 2001 |
[Cyclosporine-verapamil interaction].
Topics: Adult; Behcet Syndrome; Cyclosporine; Drug Interactions; Female; Humans; Verapamil | 1992 |
[Low dose cyclosporin treatment for ocular lesions of Behçet's disease].
Topics: Adult; Behcet Syndrome; Cyclosporine; Drug Administration Schedule; Female; Humans; Kidney Diseases; Male; Middle Aged; Nervous System Diseases | 1992 |
Generalized myositis in Behçet disease: treatment with cyclosporine.
Topics: Adult; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Humans; Male; Myositis; Prednisolone | 1992 |
Cyclosporine therapy for autoimmune disease.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Behcet Syndrome; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Kidney Diseases; Psoriasis | 1992 |
Clinical-radiological correlation in the evolution of a neuro-Behçet's syndrome: case report.
Topics: Adult; Behcet Syndrome; Brain; Chlorambucil; Cyclosporine; Drug Therapy, Combination; Encephalitis; Humans; Magnetic Resonance Imaging; Male; Prednisolone; Tomography, X-Ray Computed | 1991 |
[Decision on therapeutic course and follow-up study of collagen diseases].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aortic Arch Syndromes; Behcet Syndrome; Collagen Diseases; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Methylprednisolone; Mixed Connective Tissue Disease; Sjogren's Syndrome | 1991 |